AstraZeneca is one of the world's leading pharmaceutical companies. Backed by a strong research base and extensive manufacturing and commercial skills, the company provides a powerful range of products for six important areas of healthcare - gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection. With its headquarters based in UK, AstraZeneca has its Rand D facilities basedin Sweden, USA, Japan and India. The company sells its products in over 100 countries, manufactures in 27 and has major research centres in 11. It employs over 65,000 people worldwide and values the diversity of skills and abilities that they bring to the business. Rand D is based in Sweden, the UK, the USA, Canada, France, India and Japan. The company is recognised as having one of the best development pipelines in the industry and spends over dollar14 million each working day to maintain a flow of new medicines designed to meet patients needs. AstraZeneca invests over USdollar 3.4 billion a year on Rand D activities including Discovery Research. The company worldwide sales in 2005 totalled dollar24 billion.
AstraZeneca in India has its R and D, Manufacturing and Marketing offices in Bangalore, thus bringing to India an entire package of experience and investment.
AstraZeneca India Pvt. Limited AZIPL is an integral part of the global organisation with a mandate to discover new chemical entities for the treatment of infectious diseases of the developing world. The Company, with its state-of-the-art facility in Bangalore, is dedicated to the Discovery of Novel Therapies for the Developing World diseases , an unique and brave commitment from one of the world s leading pharmaceutical companies in the world, a recognition of the talent in India and the environment at Bangalore, a pledge to work together to combat diseases of the developing world like Tuberculosis, which needs a major research thrust to find newer therapies. The Rand D facility in India has >90 scientists of international repute working together as a team, contributing effectively to the goal of discovering new and novel therapeutic agents. The new state-of-the-art Process Rand D facility, adjacent to the recently built Rand D facility, covering 6000 sq mts on a 3.5 acre plot, will be built to house a team up to 50 more scientists plus associated support staff. The co-location of the Discovery and Process Rand D scientists will help AstraZeneca to maximize the scientific interactions and enable shared use of the Rand D infrastructure.
Nature of Business
Posted on: [02-JUN-10]
Happenings / News / Press Coverage
29-June-2007 FOGSI to use AIR, Doordarshan to spread Safe Motherhood’ message
01-June-2007 Bhasker Iyer to lead AstraZeneca as Area Vice President South East Asia and India. Anandh Balasundaram to head AstraZeneca Pharma India Ltd.
21-Mar-2007 AstraZeneca Inaugurates State-of-the-Art Global Process R and D lab in Bangalore
19-Mar-2007 AstraZeneca Research Foundation India Makes Investments in Indian Science To Ensure Pioneering Science Sponsorship Continues
15-Mar-2007 AstraZeneca awarded Best Safe Industry by National Safety Council, Karnataka Chapter.
18-Dec-2006 AstraZeneca Receives the 2006 Indian Manufacturing Excellence Platinum Award in Healthcare.
04-Dec-2006 AstraZeneca India to Showcase 12 Posters at the ICGEB Conference, Delhi.
05-May-2006 Samarop Ceremony
18-Apr-2006 SuPrabha Ganga Yatra
24-Mar-2006 World TB Day - AstraZeneca R and D Bangalore Initiatives
03-Mar-2006 AstraZeneca Consolidates its Anti-Infectives Portfolio with the Acquisition of Vancocin CP from Eli Lilly
22-Nov-2005 King Carl XVI Gustaf Of Sweden Visits AstraZeneca R andD Centre Of Excellence in Bangalore
21-Oct-2005 FOGSI launches ‘Anmol Anchal’ Safe Motherhood campaign in partnership with AstraZeneca India .
11-Aug-2005 AstraZeneca receives two Pharmaceutical Achievement Awards in recognition of business and community partnerships
17-Jan-2005 AstraZeneca starts construction of US Dollar10 m process R and D facility in Bangalore .
Astrazeneca Pharma India Limitedhttp://www.indiamart.com/astrazeneca-pharma/
Bellary Road, Hebbal, Bengaluru - 560024, Karnataka, India